1. COMMUNITY UPDATE FOR MSM ADVOCATES
The Global Fund’s New Funding Model:
Decisions at the November 2013 Board Meeting!
November 2013
WHY IS THE NEW FUNDING MODEL IMPORTANT FOR MSM?
The Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM) launched their New Funding Model (NFM)
in early 2013. The NFM is designed to allow for greater flexibility, predictability, and simplicity in the application
process. The NFM also aims to improve impact and management of grants, enhancing civil society
participation to help ensure investments are strategically targeting the right intervention and the right
population.
The NFM also strives to support continued funding for key affected populations (KAPs),1
including men who
have sex with men (MSM). Civil society has an invaluable role to play mobilizing country-level communities
and pushing national governments to address the needs of the communities the most affected by HIV. The
current period of transition to the NFM presents a unique opportunity to reassess the roles that civil society and
key populations can and should play in the development and implementation of GFATM grants.
For MSM and other KAPs advocates, this period represents an unprecedented opportunity to shape the NFM,
ensuring it is responsible to KAPs and responsive to human rights concerns. The Global Forum on MSM and
HIV (MSMGF) has worked closely with in-country advocates to monitor the transition to and implementation of
the NFM during the year 2013, identifying a number of issues that may impact HV programming for MSM and
other KAPs.
In preparation for the full launch of the NFM in 2014, this update summarizes key issues discussed at the most
recent GFATM Board meeting this November, with a focus on issues of particular concern for civil society
organizations and KAPs advocates. Future briefings will focus on key issues as they arise, with special
attention to recommendations for country-level advocates to prepare for the full launch of the NFM in early
2014.
1 Different governments and organizations have different definitions of the groups included in “Key Affected Populations.” The GFATM defines KAPs
to include groups disproportionately impacted by HIV when compared with the general population, including gay men and other MSM, women and
men who inject drugs, sex workers, transgender people, people living with diseases, migrants and mobile populations, and incarcerated persons.

2. WHAT IS THE TIMELINE FOR ROLLOUT?
November 2013 December 2013 January 2014 February 2014 March 2014
Late month:
Sharing of initial
guidance on
regional
application
management.
On the 3rd: Donors make
pledges at the GFATM
Replenishment
Conference in
Washington D.C., forming
the basis of funds
available for the 2014-
2016 period.
Late month: GFATM will
make available a
standard format for
submitting an application
for funding programs to
fight the three diseases,
including joint
applications for HIV and
TB.
Late month: GFATM will
share the application
format for non-standard
grants, such as health
systems strengthening,
non-Country
Coordinating
Mechanisms (CCMs),
and regional
applications.
Late month: The
GFATM Board is
expected to
approve allocation
of funding to
country bands.2
Late month: Countries
informed of their
allocation envelopes
(indicative funding);3 full
implementation of the
New Funding Model
begins.
HOW WILL THE NEW ELIGIBILITY CRITERIA AFFECT CIVIL SOCIETY?
During the last GFATM Board Meeting, held 7-8 November in Geneva, major issues for civil society included
Board approval of revisions to the Eligibility, Counterpart Financing, and Prioritization (ECFP) Policy. The most
significant modifications to the ECFP Policy concern changes in eligibility requirements for funding, resulting in
countries becoming newly eligible or newly ineligible as a result of a country’s income level or disease burden.
It is likely that these changes will render a number of middle-income countries (MICs) ineligible for funding, and
civil society representatives at the meeting argued that there is a public health and human rights imperative for
the GFATM to remain active in MICs. Civil society representatives, including KAPs and PLHIV from numerous
regions, were deeply concerned that some of the proposed revisions could have a significant impact on the
ability of KAPs to access prevention and treatment for HIV and tuberculosis. The GFATM’s continued
engagement in MICs is required in order to maximize and sustain progress made against epidemics of (MDR)-
TB and HIV, to ensure the sustainability of the response to the HIV epidemic in countries newly ineligible for
funding, and to support the critical role of civil society in these processes.
Revised Eligibility Criteria for Single Country Applicants
Under the NFM, a country’s eligibility for funding is determined primarily by the country’s gross national income
(GNI) and HIV prevalence rates. Country eligibility is scored by a new formula that combines these two factors,
disqualifying countries with higher GNIs and lower HIV prevalence rates. The GFATM’s Strategy, Investment,
and Impact Committee (SIIC) will meet in February 2014 to finalize the formula and announce to the public,
after GFATM Board approval, the list of eligible countries and the amount they are able to receive.
2 Country band: bands have been described as a way to meet the objectives of the GFATM in shaping the profile of its portfolio and to allow for
flexibility in assigning funding within a band to enable for fair competition. Countries would be allocated to country bands according to disease
burden and Gross National Income per capita (GNIpc).
3 During the country dialogue, the GFATM Secretariat will communicate an “indicative funding” ceiling. This is core funding a country can expect to
be granted, and it should be used as a guidepost in the development of the concept note.

3. At the GFATM’s most recent Board meeting, the Board decided to revise eligibility criteria for single country
applicants to change the GNI cutoff, expanding the number of countries that are considered “too wealthy” to
receive GFATM funds, including more middle-income countries (MIC). This could have a negative effect on
numerous countries in Eastern Europe, Central Asia, Latin America, the Caribbean, the Middle East, and North
Africa. Many of these countries have concentrated epidemics among KAPs and governments that provide little
or no funding for KAPs programming. Without GFATM support, HIV prevention and treatment for KAPs may be
in jeopardy, as many KAPs programs in these regions exist only through this funding channel.
Once the formula for eligibility is implemented, each country’s eligibility for funding will be reassessed on an
annual basis. This means that the GFATM will rerun the formula every year using updated GNI and HIV
prevalence rates to determine whether each country is still eligible for funding.
Because the GFATM’s standard grant period is 3 years, it is possible that a country will be eligible in year 1 but
become ineligible for funding in year 2 or 3 of the grant they received. These countries, called “transitioning
countries,” will have a “transition period” during which they will continue to receive GFATM funds as they
transition out of GFATM support. The amount received during the transition period will be determined by the
GFATM Secretariat, and it is expected to be equal to or greater than the equivalent of one year of funding (i.e.
one third of the amount that would be allocated using the formula). This transition period will also be afforded
to countries that currently receive GFATM support but are rendered ineligible by the introduction of the new
formula in February 2014. While transitional provisions are modest, they are designed to allow transitioning
countries to plan and budget to take over critical program components that address the poorest and most
marginalized KAPs.
As a result of pressure from the implementers block (composed of implementer countries and civil society
constituencies) at the November Board meeting, a new decision point has been included that requests the SIIC
to explore further options and recommendations to refine the GFATM’s approach to transitioning countries;
findings are expected to be announced by 2014. Consideration of public health indicators to measure progress
in sustaining and enhancing gains against the 3 diseases will be included in order to refine the amount
available for transitioning countries.
Revised Eligibility Criteria for Multiple Country (Regional) Applicants
Responses to HIV, tuberculosis, and malaria sometimes require a regional approach with cross-border
interventions. Under the NFM, the GFATM will continue to support strategically-focused regional applications
that achieve high impact, represent value for money, and successfully reach KAPs. Regional proposals create
opportunities for sharing experiences and building stronger support networks for KAPs in countries that have
common cultural, linguistic, and historic values, regardless of their income level.
At the same time, regional projects focused on advocacy provide opportunities for civil society organizations
(CSOs) to coordinate efforts, build coalitions, and engage a range of external stakeholders in activities that are
otherwise difficult to implement at a national level, particularly in countries where governments are reluctant to
increase funding for KAPs programs. High-income countries could benefit favorably from such projects, as
higher income status does not necessarily equate willingness of certain governments to pay for services
targeting KAPs.
While the new formula may disqualify a country from receiving GFATM funds as a single country applicant, that
same country may still be able to access GFATM funds as part of a regional proposal. However, for a regional
proposal to be eligible for funding, more than half of the countries included in the proposal must meet the
criteria for eligibility as a single country applicant. This decision is critical to MSM advocates from current or
future ineligible countries, as it will allow them to access funding support for their activities by including these
activities as part of a regional proposal.
The GFATM Board will decide the exact amount of funding reserved for regional proposals at its March 2013
meeting. While full funding arrangements for regional proposals are not yet clear, advocates expect that less
funding will be available for regional proposals under the NFM than under the previous model. Civil society

4. representatives expect that a large number of regional proposals will be submitted in 2014, and it is unlikely
that the funding reserved will support all of them. The GFATM Secretariat has stated that countries could
transfer some of their indicative allocation to the principal recipient/lead agency of a regional proposal.
However, it is unlikely that many conservative governments will agree to do so, and it is still unclear how the
GFATM will respond when this issue comes up.
With this in mind, all regional applications will follow a two-step process under the NFM. Applicants will first be
asked to submit a short expression of interest that makes the case for their regional proposal, including
expected impact and funding needed. Eligible expressions of interest will then receive an invitation to submit a
concept note, and applicants will be given an indicative funding amount.
In order to ensure that there is an equal opportunity to access funding set aside for regional applications, there
will be two windows for applicants to express interest: one in April 2014 and the other in April 2015. It is
expected that approximately half the available funds will be set aside for each year. By January 2014, the
GFATM will make available all tools and guidance needed to submit an expression of interest.
For more information, please refer to Board Decision 5 and Board Document Global Fund-B30-06, “New
Funding Model: Eligibility, Counterpart Financing and Prioritization Policy Revision,” available at
www.theglobalfund.org/en/board/meetings/thirtieth.
WHEN CAN COUNTRIES APPLY?
The GFATM’s transition to the NFM is currently underway, taking place in 2 distinct phases – the Early
Application Phase and the Interim Application Phase. Two select groups of countries were chosen to apply for
funds during the two transition phases, respectively.
In the Early Application Phase, beginning in February 2013, the GFATM selected a small group of 6 early
applicant countries to pilot and test the model: Zimbabwe, El Salvador, Myanmar, Democratic Republic of
Congo, Kazakhstan, and the Philippines. As of November 2013, 9 grants have been signed (2 for El Salvador,
6 for Myanmar, 1 for Zimbabwe).
The Interim Application Phase began in April 2013, which invited interim applicant countries to apply for
funding renewal opportunities on existing grants (List of interim applicants). Country selection criteria included:
(1) eligibility based on a draft version of the new formula that accounts for GNI and HIV prevalence; (2) the
potential for program disruption in 2013 and 2014 (antiretroviral drug stock outs, for example); and (3) the
potential to achieve rapid impact and results. As of November 2013, funding requests received in the Interim
Application Phase are on track, with 33 of 61 grant programs having completed preliminary reviews and
scheduled to receive funding in 2014.
Lessons learned and community feedback received during the transition period will be incorporated into an
updated NFM, which will be fully launched in 2014. In anticipation of a large wave of grants in 2014, the
GFATM is training country-level staff on the NFM. They are also making an effort to ensure that implementing
countries receive sufficient technical support for developing new grant proposals.
Total funding for the NFM through 2016 will be determined after the replenishment conference (December
2013) and the next GFATM Board meeting (February 2014). The GFATM is hoping to raise necessary funds
by or before the start of 2014. Based on early communications from the GFATM Secretariat, funding decisions
will be quarterly and tied to application submission periods throughout the allocation cycle.
NEXT STEPS
The MSMGF is expanding its work as a technical partner throughout the implementation of the NFM and will
provide regular updated briefings in order to improve the level of knowledge and engagement of country-level
MSM to ensure sustainability of HIV programs for the most affected communities. Future briefings will examine
key issues as they arise, with a focus on recommendations and guidelines for country-level advocates to
prepare and be ready for the full launch of the NFM early 2014.

5. For any questions, please contact Nadia Rafif, Senior Policy Advisor, nrafif@msmgf.org, and Noah Metheny,
Director of Policy, nmetheny@msmgf.org.